Eligibility Prostate Cancer Based on a Rise of the PSA > 4 ng / mL. NCT02050542

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient from 45 to 75 years old;
Descripción

ID.1

Tipo de datos

boolean

serum level of psa > 4,0 ng / ml;
Descripción

ID.2

Tipo de datos

boolean

multiparametric prostate irm, performed before inclusion and which confirm the diagnosis of suspected target;
Descripción

ID.3

Tipo de datos

boolean

no opposition of the patient notified in the medical record
Descripción

ID.4

Tipo de datos

boolean

patient member in a national insurance scheme.
Descripción

ID.5

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous prostate biopsy;
Descripción

ID.6

Tipo de datos

boolean

suspicious digital rectal examination;
Descripción

ID.7

Tipo de datos

boolean

serum psa > 20,0 ng / ml;
Descripción

ID.8

Tipo de datos

boolean

treatment with 5 alpha reductase inhibitor during the last 3 months;
Descripción

ID.9

Tipo de datos

boolean

untreated urinary infection
Descripción

ID.10

Tipo de datos

boolean

Similar models

Eligibility Prostate Cancer Based on a Rise of the PSA > 4 ng / mL. NCT02050542

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patient from 45 to 75 years old;
boolean
ID.2
Item
serum level of psa > 4,0 ng / ml;
boolean
ID.3
Item
multiparametric prostate irm, performed before inclusion and which confirm the diagnosis of suspected target;
boolean
ID.4
Item
no opposition of the patient notified in the medical record
boolean
ID.5
Item
patient member in a national insurance scheme.
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
previous prostate biopsy;
boolean
ID.7
Item
suspicious digital rectal examination;
boolean
ID.8
Item
serum psa > 20,0 ng / ml;
boolean
ID.9
Item
treatment with 5 alpha reductase inhibitor during the last 3 months;
boolean
ID.10
Item
untreated urinary infection
boolean